Bayview Pharmacy is proud to offer a compounded formulation of Estradiol 0.01%/Estriol 0.2% in a topical cream format. This semisolid preparation is dispensed in a pump mechanism, designed for convenient and controlled application on the skin. It is specifically designed for localized treatment or absorption of the active ingredients, estradiol and estriol.

This unique formulation is used to treat a variety of conditions, including vulvovaginal atrophy, lichen sclerosus, lichen planus, genitourinary syndrome of menopause, and postmenopausal vaginal dryness. The combination of estradiol and estriol works synergistically to reduce inflammation, improve vaginal lubrication, and alleviate symptoms of vaginal atrophy. Additionally, it aids in reducing the risk of recurrent urinary tract infections and enhancing overall vaginal health.

While this formulation is an effective treatment for the aforementioned conditions, it is important to note that it may cause skin irritation in some individuals. Therefore, it should be used with caution and under the guidance of a healthcare professional. Always follow the instructions provided by your prescriber to ensure safe and effective use of this medication.

If you have any questions or concerns about this Estradiol 0.01%/Estriol 0.2% topical cream, or how it can be used to treat your specific condition, please do not hesitate to contact us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide you with the information and support you need.

This compounded formulation of Estradiol 0.01%/Estriol 0.2% Topical Cream is a semisolid preparation designed for convenient and controlled application on the skin. It is primarily used for the treatment of various conditions such as Vulvovaginal Atrophy, Lichen Sclerosus, Lichen Planus, Genitourinary Syndrome of Menopause, and Postmenopausal Vaginal Dryness. It is crucial to note that this formulation is not recommended for use in women who are pregnant, breastfeeding, or those with known or suspected estrogen-dependent neoplasia.

Patients are advised to use the lowest effective dose for the shortest duration necessary to achieve the desired therapeutic effect. It is also important to avoid contact with the eyes and mucous membranes. In case of accidental contact, the area should be thoroughly washed with water. Regular monitoring for signs and symptoms of estrogen-related adverse reactions is recommended. These may include nausea, vomiting, changes in vaginal bleeding patterns, breast tenderness, and changes in libido.

If any of these adverse reactions occur, patients should immediately contact their healthcare provider. This formulation is designed to provide localized treatment or absorption of active ingredients, ensuring targeted and effective treatment. It is dispensed in a pump mechanism, allowing for easy and controlled application. Please do not hesitate to reach out if you have any questions or concerns regarding this formulation.

Estradiol 0.01%/Estriol 0.2% Topical Cream is a specially compounded medication designed to address various conditions associated with menopause. These conditions include vulvovaginal atrophy, lichen sclerosus, lichen planus, genitourinary syndrome of menopause, and postmenopausal vaginal dryness. The cream is intended for direct application to the affected area, usually once or twice daily, but should not be used on broken or irritated skin.

The cream contains two key active ingredients: Estradiol and Estriol. Estradiol is a form of estrogen, a hormone that plays a crucial role in regulating the female reproductive system. Estriol, on the other hand, is a milder form of estrogen that aids in reducing inflammation and promoting skin health. The combination of these two hormones helps alleviate menopausal symptoms such as vaginal dryness, itching, and burning.

When used for vulvovaginal atrophy, the cream works to reduce inflammation and enhance skin health, while also alleviating symptoms like itching, burning, and dryness. Similarly, for conditions like lichen sclerosus and lichen planus, the cream helps to reduce inflammation, improve skin health, and alleviate associated symptoms. For genitourinary syndrome of menopause and postmenopausal vaginal dryness, the cream works in the same way, reducing inflammation, promoting skin health, and alleviating discomfort.

If you have any queries about Estradiol 0.01%/Estriol 0.2% Topical Cream or how it can help manage your condition, please do not hesitate to get in touch. We are here to assist you.

This compounded formulation of Estradiol 0.01%/Estriol 0.2% Topical Cream is a semisolid preparation designed for convenient and controlled application on the skin. It is primarily used for localized treatment or absorption of active ingredients. This formulation may also be used to treat a variety of conditions such as vaginal dryness, itching, burning, and irritation. It has been found effective in reducing the risk of recurrent urinary tract infections, bacterial vaginosis, and vulvovaginal candidiasis in postmenopausal women. If you have any questions about the use of this formulation, please do not hesitate to reach out to us.